Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Clinical trial NCT00892775 · COMPLETED

Trial details

NCT number: NCT00892775
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Measles Varicella Mumps Rubella

Start date: 2009-06-03
Primary completion: 2010-09-17
Enrollment: 501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.